APO RESEARCH · REPORT
Intravenous Solutions (Colloids)
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Product & engineering
Understand the product.
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Selected research
Market Structure
Global Intravenous Solutions (Colloids) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.
This report provides an overview of the global Intravenous Solutions (Colloids) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Intravenous Solutions (Colloids) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Intravenous Solutions (Colloids) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Solutions (Colloids) market size, projected growth trends, production technologies, key applications, and end-use industries.
Intravenous Solutions (Colloids) Segment by Company
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.
Intravenous Solutions (Colloids) Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Intravenous Solutions (Colloids) Segment by Application
Hospital and Clinics
Ambulatory
Home Care
Intravenous Solutions (Colloids) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions (Colloids) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions (Colloids) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions (Colloids).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Intravenous Solutions (Colloids) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous Solutions (Colloids) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intravenous Solutions (Colloids) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Intravenous Solutions (Colloids) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Peripheral Parenteral Nutrition
- Total Parenteral Nutrition
Applications
- Hospital and Clinics
- Ambulatory
- Home Care
Companies covered
- ICU Medical Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Baxter
- Amanta Healthcare
- Terumo Medical Corporation
- Grifols S.A.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Intravenous Solutions (Colloids) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Intravenous Solutions (Colloids) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Intravenous Solutions (Colloids) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Intravenous Solutions (Colloids) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Intravenous Solutions (Colloids) Market Dynamics
- 2.1 Intravenous Solutions (Colloids) Industry Trends
- 2.2 Intravenous Solutions (Colloids) Industry Drivers
- 2.3 Intravenous Solutions (Colloids) Industry Opportunities and Challenges
- 2.4 Intravenous Solutions (Colloids) Industry Restraints
3 Intravenous Solutions (Colloids) Market by Manufacturers
- 3.1 Global Intravenous Solutions (Colloids) Revenue by Manufacturers (2021-2026)
- 3.2 Global Intravenous Solutions (Colloids) Sales by Manufacturers (2021-2026)
- 3.3 Global Intravenous Solutions (Colloids) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Intravenous Solutions (Colloids) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Intravenous Solutions (Colloids) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Intravenous Solutions (Colloids) Manufacturers, Product Type & Application
- 3.7 Global Intravenous Solutions (Colloids) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Intravenous Solutions (Colloids) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Intravenous Solutions (Colloids) Players Market Share by Revenue in 2025
- 3.8.3 2025 Intravenous Solutions (Colloids) Tier 1, Tier 2, and Tier 3
4 Intravenous Solutions (Colloids) Market by Type
- 4.1 Intravenous Solutions (Colloids) Type Introduction
- 4.1.1 Peripheral Parenteral Nutrition
- 4.1.2 Total Parenteral Nutrition
- 4.2 Global Intravenous Solutions (Colloids) Sales by Type
- 4.2.1 Global Intravenous Solutions (Colloids) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Intravenous Solutions (Colloids) Sales by Type (2021-2032)
- 4.2.3 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2021-2032)
- 4.3 Global Intravenous Solutions (Colloids) Revenue by Type
- 4.3.1 Global Intravenous Solutions (Colloids) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Intravenous Solutions (Colloids) Revenue by Type (2021-2032)
- 4.3.3 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2021-2032)
5 Intravenous Solutions (Colloids) Market by Application
- 5.1 Intravenous Solutions (Colloids) Application Introduction
- 5.1.1 Hospital and Clinics
- 5.1.2 Ambulatory
- 5.1.3 Home Care
- 5.2 Global Intravenous Solutions (Colloids) Sales by Application
- 5.2.1 Global Intravenous Solutions (Colloids) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Intravenous Solutions (Colloids) Sales by Application (2021-2032)
- 5.2.3 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2021-2032)
- 5.3 Global Intravenous Solutions (Colloids) Revenue by Application
- 5.3.1 Global Intravenous Solutions (Colloids) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Intravenous Solutions (Colloids) Revenue by Application (2021-2032)
- 5.3.3 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2021-2032)
6 Global Intravenous Solutions (Colloids) Sales by Region
- 6.1 Global Intravenous Solutions (Colloids) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Intravenous Solutions (Colloids) Sales by Region (2021-2032)
- 6.2.1 Global Intravenous Solutions (Colloids) Sales by Region (2021-2026)
- 6.2.2 Global Intravenous Solutions (Colloids) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Intravenous Solutions (Colloids) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Intravenous Solutions (Colloids) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Intravenous Solutions (Colloids) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Intravenous Solutions (Colloids) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Intravenous Solutions (Colloids) Revenue by Region
- 7.1 Global Intravenous Solutions (Colloids) Revenue by Region
- 7.1.1 Global Intravenous Solutions (Colloids) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Intravenous Solutions (Colloids) Revenue by Region (2021-2026)
- 7.1.3 Global Intravenous Solutions (Colloids) Revenue by Region (2027-2032)
- 7.1.4 Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Intravenous Solutions (Colloids) Revenue (2021-2032)
- 7.2.2 North America Intravenous Solutions (Colloids) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Intravenous Solutions (Colloids) Revenue (2021-2032)
- 7.3.2 Europe Intravenous Solutions (Colloids) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Intravenous Solutions (Colloids) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Intravenous Solutions (Colloids) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Intravenous Solutions (Colloids) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Intravenous Solutions (Colloids) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 ICU Medical Inc.
- 8.1.1 ICU Medical Inc. Company Information
- 8.1.2 ICU Medical Inc. Business Overview
- 8.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
- 8.1.5 ICU Medical Inc. Recent Developments
- 8.2 B. Braun Melsungen AG
- 8.2.1 B. Braun Melsungen AG Company Information
- 8.2.2 B. Braun Melsungen AG Business Overview
- 8.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
- 8.2.5 B. Braun Melsungen AG Recent Developments
- 8.3 Fresenius Kabi AG
- 8.3.1 Fresenius Kabi AG Company Information
- 8.3.2 Fresenius Kabi AG Business Overview
- 8.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
- 8.3.5 Fresenius Kabi AG Recent Developments
- 8.4 Baxter
- 8.4.1 Baxter Company Information
- 8.4.2 Baxter Business Overview
- 8.4.3 Baxter Intravenous Solutions (Colloids) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Baxter Intravenous Solutions (Colloids) Product Portfolio
- 8.4.5 Baxter Recent Developments
- 8.5 Amanta Healthcare
- 8.5.1 Amanta Healthcare Company Information
- 8.5.2 Amanta Healthcare Business Overview
- 8.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
- 8.5.5 Amanta Healthcare Recent Developments
- 8.6 Terumo Medical Corporation
- 8.6.1 Terumo Medical Corporation Company Information
- 8.6.2 Terumo Medical Corporation Business Overview
- 8.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
- 8.6.5 Terumo Medical Corporation Recent Developments
- 8.7 Grifols S.A.
- 8.7.1 Grifols S.A. Company Information
- 8.7.2 Grifols S.A. Business Overview
- 8.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
- 8.7.5 Grifols S.A. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Intravenous Solutions (Colloids) Value Chain Analysis
- 9.1.1 Intravenous Solutions (Colloids) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Intravenous Solutions (Colloids) Production Mode & Process
- 9.2 Intravenous Solutions (Colloids) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Intravenous Solutions (Colloids) Distributors
- 9.2.3 Intravenous Solutions (Colloids) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst